Location History:
- Saint Paul, MN (US) (2015 - 2016)
- Minneapolis, MN (US) (2019)
Company Filing History:
Years Active: 2015-2019
Title: Innovations by Blake D Walburg
Introduction
Blake D Walburg is an accomplished inventor based in Saint Paul, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dry powder inhalers. With a total of three patents to his name, Walburg's work is focused on improving the delivery of biologically active substances.
Latest Patents
Walburg's latest patents revolve around dry powder inhalers. The disclosures describe innovative powder inhalers and storage cassettes that include a compartment housing an elongate carrier preloaded with multiple doses of finely divided powder. This powder comprises a biologically active substance. The compartment is designed to seal the preloaded doses within, allowing the carrier to be advanced from the compartment to the chamber through an exit equipped with a moisture barrier sealing system. This sealing system is uniquely configured to be relaxable during the advancement of the carrier. It remains in a sealing configuration prior to the carrier's advancement, relaxes upon advancement, and returns to its sealing configuration after the release of the powder.
Career Highlights
Blake D Walburg is currently associated with Adamis Pharmaceuticals Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the efficacy of inhalation therapies, which are crucial for patients with respiratory conditions.
Collaborations
Walburg has collaborated with notable colleagues, including Peter D Hodson and Stephen W Stein. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge pharmaceutical solutions.
Conclusion
Blake D Walburg's contributions to the field of inhalation therapies through his patents and collaborations highlight his commitment to improving patient care. His work at Adamis Pharmaceuticals Corporation continues to pave the way for advancements in pharmaceutical delivery systems.